Moderna

General Information
Business:

 

Messenger RNA, or mRNA, transfers the information stored in our genes to the cellular machinery that makes all the proteins required for life. Our genes are stored as sequences of DNA which contain the instructions to make specific proteins. DNA serves as a hard drive, safely storing these instructions in the nucleus until they are needed by the cell. We see mRNA functioning as the “software of life.” Every cell uses mRNA to provide real time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 680
Founded: 2009
Contact Information
Address 200 Technology Square Cambridge, MA 02139, US
Phone Number (617) 714-6500
Web Address http://www.modernatx.com
View Prospectus: Moderna
Financial Information
Market Cap $7565.8mil
Revenues $191.6 mil (last 12 months)
Net Income $-299.2 mil (last 12 months)
IPO Profile
Symbol MRNA
Exchange NASDAQ
Shares (millions): 26.3
Price range $23.00 - $23.00
Est. $ Volume $604.3 mil
Manager / Joint Managers Morgan Stanley/ Goldman Sachs/ J.P. Morgan
CO-Managers BofA Merrill Lynch/ Barclays/ Piper Jaffray/ Bryan, Garnier/ Oddo BHF/ Oppenheimer/ Needham/ Chardan
Expected To Trade: 12/7/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change